Section: Breast Curriculum: Curriculum, page 11

Reduces risk of Breast Ca death by 16%

Aim

Adverse effects

  • Anxiety related to recall
  • Open surgical biopsy sometimes performed for what turns out to be benign disease
  • Overdiagnosis
    • E.g. Will low grade DCIS ever threaten this patient’s life?

Breastscreen Aotearoa

  • 45-69yrs in NZ (since 1988)
  • 2yrly Mamogram, MLO + CC
    • 2 views increases detection of small cancers by 42%
      • Ideal film density = 1.5-1.9
      • Double reading improves sensitivity by 5-10%
      • 98% sensitive in older population
  • Clinical and self-exam don’t decrease mortality

Findings

  • Well defined mass
    • Almost always benign, PPV <1% for Ca
  • Ill-defined mass
    • Always requires further assessment, PPV 35-50%
  • Spiculated mass
    • PPV 50-90%
  • Clustered microcalcifications
    • PPV 15% for Ca
    • Account for high amount of recalls
    • Most common way to pick up DCIS

BI-RADS assessment categories

BI-RADS breast density

Targets

  • Open Bx ≤ 1%
  • Aim for 90% of benign specimens < 30g
  • Interval malignancy rates
    • < 0.6/1000 1st year
    • < 1.2/1000 2nd year
  • Screen detected Ca: Node -ve: ≥ 70% Size ≤ 14mm
  • Recall rate < 7%
  • 80% of these benign
  • For every 10,000 screened – 27-30 invasive ca, 5-10 DCIS
  • 55% < 15mm

Factors affecting the effectiveness of screening

  • HRT or implants
  • Increases breast density, reduces mammography sensitivity

Most important screen detected cancers

  • High grade DCIS
    • Will progress to G2/3 invasive ca within 3yrs
  • Grade 2 + 3 tumours

Breast Screening Evidence

  • Mortality
    • 15-20% reduction in women 40-69
      • Mortality ↓ not observed in 40-49yr group
        • 20% of breast Ca are diagnosed in women in their 40s (screening benefits unclear)
    • But also 30% ↑ risk (≈ 0.5% absolute risk) of over diagnosis / overtreatmen
  • Overall
    • For every 2000 women screened over 10yrs
      • ONE will have her life prolonged
      • 10 healthy women will incorrectly be diagnosed as “Breast Ca” and treated unnecessarily
  • 25% decrease in rate of stage II / advanced CA
  • False -ves:
    • ~ 10% of cancers are missed by mammography in women aged 50-59
    • 25% are missed in women 40-49
  • Radiation risk
    • Estimate for screening between 50-64 causing cancer is approx. 1/20,000 <0.4 cGy per view